MedPath

Venn Biosciences Corporation

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:2

Trial Phases

0 Phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Non-invasive Identification of Colorectal Cancer and Adenomas in Early Stages

Completed
Conditions
Colorectal Cancer
First Posted Date
2022-07-06
Last Posted Date
2024-04-23
Lead Sponsor
Venn Biosciences Corporation
Target Recruit Count
3002
Registration Number
NCT05445570
Locations
🇺🇸

East View Medical Research, LLD, Mobile, Alabama, United States

🇺🇸

Paragon Rx Clinical, Santa Ana, California, United States

🇺🇸

Encore - Fleming Island Center for Clinical Research, Fleming Island, Florida, United States

and more 8 locations

Clinical Validation of the InterVenn Ovarian CAncer Liquid Biopsy

Completed
Conditions
Adnexal Mass
Ovarian Cancer
Pelvic Mass
First Posted Date
2019-02-12
Last Posted Date
2024-04-23
Lead Sponsor
Venn Biosciences Corporation
Target Recruit Count
1025
Registration Number
NCT03837327
Locations
🇺🇸

University of Southern California, Los Angeles, California, United States

🇺🇸

Bay Area Gynecology Oncology, San Jose, California, United States

🇺🇸

Palo Alto Medical Foundation, Sunnyvale, California, United States

and more 23 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.